# PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib

> **NCT00117299** · PHASE2 · COMPLETED · sponsor: **University of Helsinki** · enrollment: 45 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** PTK787/ZK222584

## Key facts

- **NCT ID:** NCT00117299
- **Lead sponsor:** University of Helsinki
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-09
- **Final completion:** 2009-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2010-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117299, "PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00117299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*